Astrocyte Pharmaceuticals develops neuroprotective drugs aimed at treating acute neurological conditions. The company focuses on innovative therapies to improve outcomes for patients with brain injuries and related disorders.
Founded
2014
Total Funding
$10M+
Total Rounds
2
First Raise
Aug 21, 2023
Latest Raise
Sep 30, 2026
New funding rounds in your inbox every week · No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 9/30/2026 | |||
1 more funding round available
Upgrade to Premium to view all historical funding rounds
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week · Free